Short boys are 2 to 3 times as likely as short girls to receive growth hormone

Short boys are three times more likely than short girls to receive recombinant human growth hormone treatment for idiopathic short stature (ISS), even though in a general pediatric population, equal proportions of both genders fall under the height threshold designating ISS. Researchers who analyzed records of over 283,000 US children and adolescents found a clear-cut and persistent gender bias in the provision of treatment.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1Sg7p8u